Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 17/20 | 0.58 |
| ▸ | CRBN | Q96SW2 | 17/20 | 0.58 |
| ▸ | PDE4A | P27815 | 1/20 | 0.38 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.38 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.38 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | IKZF3 | Q9UKT9 | 1/20 | 0.35 |
| ▸ | IKZF2 | Q9UKS7 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25036590 | 1.00 | DDB1 (0.58) | DDB1CRBNPDE4APDE4BPDE4C | |
| SCHEMBL30273456 | 1.00 | DDB1 (0.58) | DDB1CRBNPDE4APDE4BPDE4C | |
| SCHEMBL30289067 | 0.92 | CRBN (0.52) | DDB1CRBNIKZF2 | |
| SCHEMBL31333960 | 0.91 | DDB1 (0.54) | DDB1CRBNIKZF2 | |
| SCHEMBL25036585 | 0.90 | DDB1 (0.46) | DDB1CRBNPDE4APDE4BPDE4C | |
| SCHEMBL30273720 | 0.89 | CRBN (0.56) | DDB1CRBNIKZF2 | |
| SCHEMBL22794968 | 0.89 | CRBN (0.62) | DDB1CRBNIKZF3IKZF2 | |
| SCHEMBL23541317 | 0.88 | CRBN (0.52) | DDB1CRBNIKZF2 | |
| SCHEMBL26237762 | 0.87 | CRBN (0.63) | DDB1CRBNIKZF3IKZF2 | |
| SCHEMBL23540574 | 0.87 | DDB1 (0.56) | DDB1CRBNIKZF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023019166-A1 | PROTEIN TYROSINE PHOSPHATASE TARGETING LIGANDS | CALICO LIFE SCIENCES LLC (US) | 2023-02-16 | — | — | WO | disclosed |